Article Details
Retrieved on: 2024-03-28 08:27:52
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article announces Andre Turenne's nomination to the board of Inventiva, a biopharmaceutical company in the global markets involved in clinical research and drug discovery, specifically for metabolic dysfunction-associated steatohepatitis (NASH).
Article found on: www.biospace.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here